Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports.
Tomonari T, Sato Y, Tanaka H, Tanaka T, Taniguchi T, Sogabe M, Okamoto K, Miyamoto H, Muguruma N, Saito Y, Imura S, Bando Y, Shimada M, Takayama T.
Tomonari T, et al. Among authors: tanaka t, tanaka h.
Medicine (Baltimore). 2020 Oct 16;99(42):e22782. doi: 10.1097/MD.0000000000022782.
Medicine (Baltimore). 2020.
PMID: 33080748
Free PMC article.